ImmunityBio (IBRX) is down -26.4%, or -$2.48 to $6.92.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBRX:
- Midday Fly By: Estee Lauder in deal talks with Puig, Smithfield reports Q4 beat
- Option traders moderately bearish in ImmunityBio with shares down 22.61%
- ImmunityBio falls -23.0%
- ImmunityBio receives FDA warning letter on Anktiva promotion
- ImmunityBio call volume above normal and directionally bullish